CLHIGH SIGNALFINANCIAL10-K

Colgate-Palmolive experienced a severe 74.5% collapse in stockholders' equity alongside significant declines in profitability and operational performance.

The dramatic erosion of stockholders' equity from $212M to just $54M represents a fundamental deterioration in the company's financial foundation that requires immediate investor attention. Combined with substantial declines in net income (-26.2%) and operating income (-22.5%), this suggests either major one-time charges, significant business headwinds, or potential accounting adjustments that have materially impacted shareholder value.

Comparing 2026-02-23 vs 2025-02-13View on EDGAR →
FINANCIAL ANALYSIS

Colgate-Palmolive's financial profile shows severe stress with stockholders' equity collapsing 74.5% while debt increased 11.9% and current liabilities rose 19%, creating a concerning leverage dynamic. Profitability declined sharply with net income falling 26.2% and operating income dropping 22.5%, while the company reduced share buybacks by 30% but increased capital expenditures by 23%. The combination of deteriorating equity, rising liabilities, declining profits, and reduced shareholder returns signals significant financial distress that investors should investigate immediately.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
-74.5%
$212.0M→$54.0M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Share Buybacks
Cash Flow
-30.4%
$1.7B→$1.2B

Buyback activity reduced 30.4% — capital being redeployed elsewhere or cash conservation underway.

Net Income
P&L
-26.2%
$2.9B→$2.1B

Net income declined 26.2% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
+22.8%
$567.0M→$696.0M

Capex increased 22.8% — ongoing investment in capacity or infrastructure for future growth.

Operating Income
P&L
-22.5%
$4.3B→$3.3B

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Current Liabilities
Balance Sheet
+19%
$5.8B→$6.9B

Current liabilities rose 19% — increased short-term obligations, watch current ratio.

Cash & Equivalents
Balance Sheet
+17.5%
$1.1B→$1.3B

Cash grew 17.5% — improving liquidity position supports investment and shareholder returns.

Total Debt
Balance Sheet
+11.9%
$7.0B→$7.8B

Debt rose 11.9% — additional borrowing for investment or operations; monitor coverage ratios.

Accounts Receivable
Balance Sheet
+10.1%
$1.5B→$1.7B

Receivables grew 10.1% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-02-23
PRIOR — 2025-02-13
ADDED
There were 801,548,028 shares of Colgate-Palmolive Company Common Stock outstanding as of January 31, 2026.
BUSINESS General Development of the Business Colgate-Palmolive Company (together with its subsidiaries, we, us, our, the Company or Colgate-Palmolive ) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet.
To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.
We do this by leveraging the global reach and penetration of our brands; building the incremental benefit of superior, science-based innovation supported by an agile and resilient supply chain; harnessing the power of best-in-class omni-channel demand generation; leading in capabilities such as data, analytics and artificial intelligence ( AI ); and evolving our high-impact, inclusive culture.
Sales of Oral, Personal and Home Care products accounted for 44%, 17% and 16%, respectively, of our total worldwide Net sales in 2025.
+7 more — sign up free →
REMOVED
There were 811,536,437 shares of Colgate-Palmolive Company Common Stock outstanding as of January 31, 2025.
BUSINESS General Development of the Business Colgate-Palmolive Company (together with its subsidiaries, we, us, our, the Company or Colgate ) is a caring, innovative growth company reimagining a healthier future for all people, their pets and our planet.
We seek to deliver consistent compounded earnings per share growth to help drive superior total shareholder return, as well as to provide Colgate people with an innovative and inclusive work environment.
We do this by developing and selling science-led products globally that make people s and their pets lives healthier and more enjoyable and by embracing our Sustainability Social Impact Strategy across our organization.
Sales of Oral, Personal and Home Care products accounted for 43%, 18% and 17%, respectively, of our total worldwide Net sales in 2024.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →